About Naproxen Sodium API
Therapeutic CategoryPain Management
CAS Number
26159-34-2
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, Korea DMF, Russia DMF
Mechanism of Action
Naproxen has analgesic, anti-inflammatory, and antipyretic properties.
The mechanism of action of NAPRELAN, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2).
Naproxen sodium is a potent inhibitor of prostaglandin synthesis in vitro. Naproxen sodium concentrations reached during therapy have produced in vivo effects. Prostaglandins sensitize afferent nerves and potentiate the action of bradykinin in inducing pain in animal models. Prostaglandins are mediators of inflammation. Because naproxen sodium is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues.
Indication
NAPRELAN is a nonsteroidal anti-inflammatory drug indicated for the treatment of:
- Rheumatoid arthritis (RA)
- Osteoarthritis (OA)
- Ankylosing spondylitis (AS)
- Tendinitis, bursitis
- Acute gout
- Primary dysmenorrhea (PD)
- The relief of mild to moderate pain
Related APIs
Elagolix Sodium
Pain Management
Ketorolac Tromethamine
Pain Management
Naproxen
Pain Management
Naproxen Sodium
Pain Management
Naratriptan Hydrochloride
Pain Management
Sumatriptan Succinate
Pain Management
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.